AtriCure Return on Tangible Equity 2010-2025 | ATRC

Current and historical return on tangible equity values for AtriCure (ATRC) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
AtriCure Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.04B $0.17B -23.15%
2024-12-31 $-0.05B $0.17B -26.95%
2024-09-30 $-0.04B $0.17B -23.46%
2024-06-30 $-0.04B $0.17B -24.43%
2024-03-31 $-0.04B $0.16B -22.84%
2023-12-31 $-0.03B $0.17B -17.91%
2023-09-30 $-0.02B $0.16B -13.99%
2023-06-30 $-0.03B $0.16B -15.45%
2023-03-31 $-0.04B $0.18B -20.56%
2022-12-31 $-0.05B $0.18B -25.38%
2022-09-30 $-0.06B $0.18B -29.95%
2022-06-30 $0.05B $0.18B 27.08%
2022-03-31 $0.05B $0.19B 33.28%
2021-12-31 $0.05B $0.21B 42.74%
2021-09-30 $0.05B $0.21B 57.88%
2021-06-30 $-0.06B $0.02B -147.10%
2021-03-31 $-0.05B $0.03B -105.95%
2020-12-31 $-0.05B $0.05B -1010.53%
2020-09-30 $-0.05B $0.05B 122.45%
2020-06-30 $-0.05B $0.05B 63.43%
2020-03-31 $-0.05B $-0.14B 65.69%
2019-12-31 $-0.04B $-0.12B 269.23%
2019-09-30 $-0.02B $-0.11B -55.00%
2019-06-30 $-0.02B $0.09B -28.88%
2019-03-31 $-0.02B $0.09B -33.16%
2018-12-31 $-0.02B $0.10B -76.19%
2018-09-30 $-0.02B $0.01B -533.33%
2018-06-30 $-0.02B $0.00B -888.89%
2018-03-31 $-0.03B $0.00B -1080.00%
2017-12-31 $-0.03B $0.01B -635.29%
2017-09-30 $-0.03B $0.00B -573.91%
2017-06-30 $-0.03B $0.01B -366.67%
2017-03-31 $-0.03B $0.00B -272.00%
2016-12-31 $-0.03B $0.01B -200.00%
2016-09-30 $-0.04B $0.02B -169.41%
2016-06-30 $-0.04B $0.02B -92.72%
2016-03-31 $-0.03B $0.02B -58.99%
2015-12-31 $-0.03B $0.03B -38.57%
2015-09-30 $-0.02B $0.08B -24.71%
2015-06-30 $-0.02B $0.09B -17.24%
2015-03-31 $-0.01B $0.09B -14.77%
2014-12-31 $-0.02B $0.09B -17.98%
2014-09-30 $-0.02B $0.09B -21.69%
2014-06-30 $-0.02B $0.09B -31.54%
2014-03-31 $-0.02B $0.09B -37.89%
2013-12-31 $-0.01B $0.03B -34.29%
2013-09-30 $-0.01B $0.04B -28.80%
2013-06-30 $-0.01B $0.04B -34.95%
2013-03-31 $-0.01B $0.04B -40.00%
2012-12-31 $-0.01B $0.01B -57.14%
2012-09-30 $-0.01B $0.01B -53.33%
2012-06-30 $-0.01B $0.02B -38.71%
2012-03-31 $-0.01B $0.02B -37.50%
2011-12-31 $-0.01B $0.02B -30.77%
2011-09-30 $0.00B $0.02B -18.18%
2011-06-30 $0.00B $0.02B -18.18%
2011-03-31 $0.00B $0.02B -18.46%
2010-12-31 $0.00B $0.02B -24.62%
2010-09-30 $-0.01B $0.02B -36.92%
2010-06-30 $-0.01B $0.02B -59.70%
2010-03-31 $-0.01B $0.02B -54.79%
2009-12-31 $-0.02B $0.02B -81.01%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.729B $0.465B
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.329B 27.82
Boston Scientific (BSX) United States $151.540B 37.94
Stryker (SYK) United States $146.015B 30.53
EssilorLuxottica (ESLOY) France $127.709B 0.00
Medtronic (MDT) Ireland $109.786B 15.56
Lonza Group Ag (LZAGY) Switzerland $49.554B 0.00
Haleon (HLN) United Kingdom $49.214B 28.03
ResMed (RMD) United States $36.648B 27.53
Agilent Technologies (A) United States $32.650B 21.28
GE HealthCare Technologies (GEHC) United States $32.569B 15.46
Terumo (TRUMY) Japan $26.857B 34.88
Insulet (PODD) United States $22.464B 88.18
Koninklijke Philips (PHG) Netherlands $21.600B 15.53
Zimmer Biomet Holdings (ZBH) United States $18.095B 11.62
Baxter (BAX) United States $15.380B 11.48
Smith & Nephew SNATS (SNN) United Kingdom $12.819B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.043B 21.03
Lantheus Holdings (LNTH) United States $5.509B 13.90
Prestige Consumer Healthcare (PBH) United States $4.190B 18.72
Perrigo (PRGO) Ireland $3.610B 9.15
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.346B 15.24
ICU Medical (ICUI) United States $3.233B 23.84
Envista Holdings (NVST) United States $3.178B 26.41
GN Store Nord (GNNDY) Denmark $2.155B 17.85
QuidelOrtho (QDEL) United States $2.102B 14.46
LeMaitre Vascular (LMAT) United States $1.865B 41.69
Acuren (TIC) United States $1.228B 0.00
AdaptHealth (AHCO) United States $1.196B 12.14
Green Thumb Industries (GTBIF) United States $1.101B 24.76
Neogen (NEOG) United States $1.077B 13.78
BioLife Solutions (BLFS) United States $1.046B 0.00
Kestra Medical Technologies (KMTS) United States $1.016B 0.00
Phibro Animal Health (PAHC) United States $0.972B 12.42
InMode (INMD) Israel $0.931B 9.38
Evolus (EOLS) United States $0.632B 0.00
CeriBell (CBLL) United States $0.619B 0.00
Curaleaf Holdings (CURLF) Canada $0.571B 0.00
Capricor Therapeutics (CAPR) United States $0.564B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.563B 0.00
Valneva SE (VALN) France $0.523B 0.00
Owens & Minor (OMI) United States $0.515B 4.27
Surmodics (SRDX) United States $0.429B 0.00
Tilray Brands (TLRY) Canada $0.412B 0.00
VAREX IMAGING (VREX) United States $0.340B 12.52
SNDL (SNDL) Canada $0.339B 0.00
Aurora Cannabis (ACB) Canada $0.313B 55.70
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.90
Sanara MedTech (SMTI) United States $0.260B 0.00
ZimVie (ZIMV) United States $0.255B 11.61
Cresco Labs (CRLBF) United States $0.250B 0.00
Canopy Growth (CGC) Canada $0.239B 0.00
Sanuwave Health (SNWV) United States $0.231B 0.00
OraSure Technologies (OSUR) United States $0.217B 0.00
Quanterix (QTRX) United States $0.217B 0.00
Verano Holdings (VRNOF) United States $0.205B 0.00
Brainsway (BWAY) Israel $0.198B 52.30
Omeros (OMER) United States $0.196B 0.00
TriSalus Life Sciences (TLSI) United States $0.195B 0.00
Biote (BTMD) United States $0.194B 5.45
High Tide (HITI) Canada $0.188B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.80
Organigram Global (OGI) Canada $0.179B 0.00
Exagen (XGN) United States $0.157B 0.00
FitLife Brands (FTLF) United States $0.136B 16.72
Vireo Growth (VREOF) United States $0.125B 0.00
Jin Medical (ZJYL) China $0.121B 0.00
Veru (VERU) United States $0.096B 0.00
MacroGenics (MGNX) United States $0.095B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.093B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Fonar (FONR) United States $0.090B 11.56
TerrAscend (TSNDF) Canada $0.089B 0.00
Agape ATP (ATPC) $0.077B 0.00
InterCure (INCR) Israel $0.069B 0.00
Zynex (ZYXI) United States $0.065B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Modular Medical (MODD) United States $0.045B 0.00
United-Guardian (UG) United States $0.038B 13.02
Nephros (NEPH) United States $0.035B 47.43
Rockwell Medical (RMTI) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00